Study is being carried out under asthma human challenge study model

Healthy volunteers are administered a pathogenic or virulent strain of virus

Infectious diseases specialist to list in London

Challenge study is providing valuable insight into biology of the virus, firm says

Company will use money from listing to meet costs for flu drug trials, develop assets

Company says reduction of capital will allow it to return value to its shareholders

hVivo will develop a new SARS-CoV-2 challenge virus based on new emerging variants

Company says HVO-001 could be included as part of potential demerger

Contract with US biotechnology company concerns a respiratory syncytial virus

Irish clinical trials group will deliberately infect healthy young volunteers with virus

Prophylactic spray could be used against Covid-19

Dublin-listed pharmaceutical services company says new deal will run for another year

Vaccine could be one of the first to provide long-term immunity from Covid-19

Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company

Guidelines will cover manufacture of agents for use in controlled infection studies

‘All we have at this point is a very promising press release. But the signs are very promising’

Contract guarantees annual revenue for Dublin listed company

Contract with UK government could be worth up to £10m

Company led by Cathal Friel recorded revenues of £7.1m for its first half

Officials warn Covid infections across country ‘a week or two’ behind Dublin